McKesson Corporation - Asset Resilience Ratio
McKesson Corporation (MCK) has an Asset Resilience Ratio of 3.51% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of McKesson Corporation to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how McKesson Corporation's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see McKesson Corporation assets under control.
Liquid Assets Composition Over Time
This chart breaks down McKesson Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore MCK long-term investments to assets to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $2.96 Billion | 3.51% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $2.96 Billion | 3.51% |
Asset Resilience Insights
- Limited Liquidity: McKesson Corporation maintains only 3.51% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
McKesson Corporation Industry Peers by Asset Resilience Ratio
Compare McKesson Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998 |
Medical Distribution | 0.08% |
|
TELES Informationstechnologien AG
XETRA:TLIK |
Medical Distribution | 0.37% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
Annual Asset Resilience Ratio for McKesson Corporation (2000–2025)
The table below shows the annual Asset Resilience Ratio data for McKesson Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 7.57% | $5.69 Billion | $75.14 Billion | +0.78pp |
| 2024-03-31 | 6.80% | $4.58 Billion | $67.44 Billion | -0.71pp |
| 2023-03-31 | 7.51% | $4.68 Billion | $62.32 Billion | +1.88pp |
| 2022-03-31 | 5.63% | $3.56 Billion | $63.30 Billion | -4.03pp |
| 2021-03-31 | 9.66% | $6.28 Billion | $65.02 Billion | +3.10pp |
| 2020-03-31 | 6.56% | $4.01 Billion | $61.25 Billion | +1.56pp |
| 2019-03-31 | 5.00% | $2.98 Billion | $59.67 Billion | +0.57pp |
| 2018-03-31 | 4.43% | $2.67 Billion | $60.38 Billion | -0.14pp |
| 2017-03-31 | 4.56% | $2.78 Billion | $60.97 Billion | -- |
| 2016-03-31 | 0.00% | $0.00 | $56.56 Billion | -- |
| 2015-03-31 | 0.00% | $0.00 | $53.87 Billion | -- |
| 2014-03-31 | 0.00% | $0.00 | $51.76 Billion | -- |
| 2013-03-31 | 0.00% | $0.00 | $34.79 Billion | -- |
| 2012-03-31 | 0.00% | $0.00 | $33.09 Billion | -- |
| 2011-03-31 | 0.00% | $0.00 | $30.89 Billion | -- |
| 2010-03-31 | 0.00% | $0.00 | $28.19 Billion | -- |
| 2007-03-31 | 4.11% | $984.00 Million | $23.94 Billion | -0.48pp |
| 2006-03-31 | 4.59% | $962.00 Million | $20.98 Billion | +4.54pp |
| 2005-03-31 | 0.05% | $9.30 Million | $18.77 Billion | -0.01pp |
| 2004-03-31 | 0.06% | $9.80 Million | $16.24 Billion | -0.02pp |
| 2003-03-31 | 0.08% | $11.50 Million | $14.35 Billion | +0.04pp |
| 2002-03-31 | 0.04% | $5.10 Million | $13.32 Billion | -0.06pp |
| 2001-03-31 | 0.10% | $11.90 Million | $11.53 Billion | -0.45pp |
| 2000-03-31 | 0.55% | $57.00 Million | $10.37 Billion | -- |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more